GlassScriptPhysician profile
Amanda Johnson Turner
NPI 1184100570
$1,524.35
in general payments reported to CMS, 2019-2025
14 companies · $510 in 2025
The $510 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15.80 · 2022: $240 · 2023: $382 · 2024: $376 · 2025: $510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,268.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,268.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $496.54 | 2022-2025 | Dupixent |
| Genzyme Corporation | $306.54 | 2022-2025 | |
| Abbvie INC. | $154.52 | 2021-2022 | |
| Glaxosmithkline, LLC. | $130.45 | 2023-2025 | Nucala |
| Pfizer INC. | $119.26 | 2023-2025 | |
| Inspire Medical Systems, INC. | $110.58 | 2023 | Inspire |
| Alk-Abello, INC | $67.53 | 2022-2025 | Grastek, Ragwitek, Odactra |
| Biohaven Pharmaceutical Holding Company LTD. | $25.45 | 2022 | |
| Tactile Systems Technology INC | $24.45 | 2023 | Flexitouch Plus, Entre Plus |
| Advanced Bionics, LLC | $22.73 | 2024 | Hires Ultra Ci Hifocus Ms Electrode |
| Smith+Nephew, INC. | $21.69 | 2024 | Coblation |
| Hikma Pharmaceuticals USA | $16.68 | 2025 | Ryaltris |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.02 | 2024 | Jardiance, Synjardy |
| Paratek Pharmaceuticals, INC. | $13.91 | 2025 | Xhance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.